Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CSF characteristics in early-onset multiple sclerosis.

D Pohl1, K Rostasy, H Reiber

  • 1Department of Pediatrics and Pediatric Neurology, Georg-August-University Goettingen, Robert-Koch-Strasse 40, 37075 Goettingen, Germany. dpohl@med.uni-goettingen.de

Neurology
|November 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Occult hernias, classification of inguinal lipomas and chronic postoperative groin pain].

Chirurgie (Heidelberg, Germany)·2025
Same author

Observation of Single-Top-Quark Production in Association with a Photon Using the ATLAS Detector.

Physical review letters·2023
Same author

Measurement of Suppression of Large-Radius Jets and Its Dependence on Substructure in Pb+Pb Collisions at sqrt[s_{NN}]=5.02  TeV with the ATLAS Detector.

Physical review letters·2023
Same author

Observation of the γγ→ττ Process in Pb+Pb Collisions and Constraints on the τ-Lepton Anomalous Magnetic Moment with the ATLAS Detector.

Physical review letters·2023
Same author

Strong Constraints on Jet Quenching in Centrality-Dependent p+Pb Collisions at 5.02 TeV from ATLAS.

Physical review letters·2023
Same author

Pharmacologic treatment of gastroparesis: What is (still) on the horizon?

Current opinion in pharmacology·2023

Cerebrospinal fluid (CSF) analysis aids in diagnosing early-onset multiple sclerosis (MS). Oligoclonal IgG in CSF is a sensitive biomarker for pediatric MS, similar to adult cases.

Area of Science:

  • Neurology
  • Immunology
  • Pediatrics

Background:

  • Multiple Sclerosis (MS) is a chronic neurological disease affecting the central nervous system.
  • Early diagnosis of MS is crucial for timely intervention and management, especially in pediatric populations.
  • Cerebrospinal fluid (CSF) analysis is a key diagnostic tool for MS.

Purpose of the Study:

  • To investigate the characteristics of CSF in patients with early-onset multiple sclerosis (EOMS).
  • To evaluate the diagnostic utility of CSF findings, including pleocytosis, blood-CSF barrier dysfunction, and oligoclonal IgG, in EOMS.
  • To compare the sensitivity of CSF biomarkers in EOMS with adult-onset MS.

Main Methods:

  • Analysis of CSF samples from 136 patients diagnosed with EOMS (disease onset before age 16).

Related Experiment Videos

  • Assessment of CSF-pleocytosis, blood-CSF barrier dysfunction, and oligoclonal IgG presence during initial diagnostic lumbar puncture.
  • Statistical comparison of biomarker prevalence and diagnostic sensitivity between EOMS and adult-onset MS cohorts.

    • Main Results:

    • CSF-pleocytosis was detected in 66% of EOMS patients.
    • Blood-CSF barrier dysfunction was observed in 13% of EOMS patients.
    • Oligoclonal IgG bands in CSF were present in 92% of EOMS patients, demonstrating high sensitivity for diagnosis.

    Conclusions:

    • CSF oligoclonal IgG is a highly sensitive biomarker for the early diagnosis of MS in children.
    • The diagnostic sensitivity of CSF oligoclonal IgG in EOMS is comparable to that observed in adult-onset MS.
    • CSF analysis, particularly oligoclonal IgG detection, is valuable for confirming MS in pediatric patients.